Astellas Pharma Top Management Personnel Changes (October 2025)

Nick Eshkenazi, Chief Digital & Transformation Officer (CDTO), departed Astellas on September 30, 20251

Effective October 1, 2025, the CDTO position was removed from top management1

Digital and Transformation functions were integrated into the Strategy function under Chief Strategy Officer Adam Pearson1

Earlier in April 2025, Astellas established new positions including Chief Research & Development Officer (CRDO), Chief Commercial & Medical Affairs Officer (CCMAO), Chief Manufacturing Officer (CMfgO), and General Counsel & Chief Ethics & Compliance Officer (GC & CECO)2

Tadaaki Taniguchi, M.D., Ph.D. was appointed CRDO; Claus Zieler was appointed CCMAO; Rao V. Mantri was appointed CMfgO; and Tatjana Dragovic was appointed GC & CECO2

Sources:

1. https://www.prnewswire.com/news-releases/astellas-announces-top-management-personnel-change-302569162.html

2. https://www.prnewswire.com/news-releases/astellas-makes-announcement-about-management-structure-302367072.html